DILACOR XR
LOE ApproachingNDAORALCAPSULE, EXTENDED RELEASE
Approved
May 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DILACOR XR is an extended-release oral capsule formulation of a small-molecule therapeutic approved in 1992. The generic mechanism of action and specific indications are not publicly detailed in available data. This product represents a legacy small-molecule franchise with potential cardiovascular or metabolic applications given its formulation class.
LOE Approaching
With LOE approaching and moderate competitive pressure (30% score), the brand team is likely in transition mode, with focus shifting from growth to lifecycle management and possible brand defense or transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on DILACOR XR offers career experience in late-lifecycle brand management, competitive defense, and managed markets negotiation during a LOE transition. This role is best suited for professionals seeking expertise in portfolio sustaining strategies, generic competition response, and post-patent landscape navigation rather than growth-phase innovation.
Brand Manager
Worked on DILACOR XR at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.